Sentences with word «esomeprazole»

Astra's esomeprazole patent was found invalid for inutility in any event because certain promises were not made out even with confidential inhouse tests (paras. 214, 215, 367).
PPIs, such as esomeprazole, lansoprazole, and omeprazole, are used for GERD (acid reflux), peptic ulcer, or heartburn.
More than 20 million Americans take prescription PPIs, including esomeprazole (Nexium), lansoprazole (Prevacid), omeprazole (Prilosec) and pantoprazole (Protonix), some of which are available over the counter.
The patent related to the «optically pure salts of esomeprazole,» which helps people with issues like gastric acid.
In 2010, that application was dismissed and Apotex commenced sales of its generic esomeprazole.
Civil: The applicants owned a patent for esomeprazole, a proton pump inhibitor used in the reduction of gastric acid, reflux esophagitis and related conditions.
Although the SCC has recently granted leave in Astra's esomeprazole action [12], both parties have acknowledged in their leave materials that the disclosure requirement is not determinative in this case (as the lower court held there was no sound prediction of the promised utility relying on material in the patent as well as Astra's internal tests).
HEARTBURN DRUGS OKAY FOR HEART: Two studies released in May had suggested that two popular prescription heartburn drugs made by AstraZeneca, Prilosec (omeprazole) and Nexium (esomeprazole), might increase users» risks of heart problems.
They include: esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazole, and are available in various different brand names.
The nausea in some people can be due to an increased production of stomach acid, so Zantac (ranitidine) or a proton pump inhibitor drug — like Prilosec (omeprazole), Prevacid (lansoprazole), or Nexium (esomeprazole) for example — can be helpful.
Canada's patent utility requirements and the workability of the promise doctrine are currently before the Supreme Court of Canada in AstraZeneca Canada Inc v Apotex Inc, in litigation over the validity of Astrazeneca's patent for the acid reflux medicine Nexium (esomeprazole).
As we reported, he followed a similar line of reasoning in his decision to deny Apotex's section 8 claim relating to esomeprazole.
The Federal Court dismissed Apotex's motion to re-open the validity phase of the patent infringement action relating to esomeprazole (AstraZeneca's NEXIUM ®).
We'll often get calls from folks who are taking Nexium (esomeprazole) and are wondering if its use will have an effect on their life insurance application and the truth is that in the vast majority of cases where the Nexium is simply being used to treat routine heart burn or GERD (gastroesophageal reflux disease) its use isn't going to play a significant role in the outcome of your life insurance application.
a b c d e f g h i j k l m n o p q r s t u v w x y z